OpenAlex
PricingAboutJobs
Log inGet started
Work

Molecular Pathways: CDK4 Inhibitors for Cancer Therapy

HTML

Year: 2014
Type: review
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-13-1551
Author: Mark A. Dickson
Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine
Language: English

Topic: Advanced Breast Cancer Therapies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: CDK4 inhibitors, CDK4, G1/S transition, retinoblastoma protein phosphorylation, p16, cyclin D, palbociclib, ribociclib, breast cancer, lymphoma, sarcoma, treatment response biomarkers, drug resistance mechanisms, combination therapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2091851204
FWCI: 4.337
Cites: 37
Cited by: 271
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security